Forecast: Basic Pharmaceutical Products Turnover in Spain

The basic pharmaceutical products turnover in Spain has shown fluctuations over the past decade, with significant growth in recent years. From 2013 to 2017, the turnover experienced moderate changes, peaking in 2014 with a 19.02% increase. The years 2018 to 2023 marked a more robust growth trajectory, with values increasing consecutively, reaching 4.72 billion Euros in 2023. The year-on-year variation shows a steady increase of 3.5% compared to 2022. The compound annual growth rate (CAGR) for the past five years stands at 3.74%. Forecasts predict a continued upward trend, with a moderate five-year CAGR projected at 1.77%, leading to an expected turnover of 5.31 billion Euros by 2028.

Future trends to watch for include:

• Impacts of technological advancements in pharmaceutical R&D.
• Regulatory changes and their effects on production and pricing.
• Global supply chain shifts and their influence on local manufacturing and export.
• Trends in public and private healthcare spending impacting demand.